Domestic Drug Producers Score A Win With Executive Order
By Ken Rapoza, CPA Industry Analyst Major pharmaceutical importers have pushed back against the White House’s proposal to support domestic labs. But on Thursday, American
By Ken Rapoza, CPA Industry Analyst Major pharmaceutical importers have pushed back against the White House’s proposal to support domestic labs. But on Thursday, American
CPA’s Take: Joe Biden responds to an NPR question on whether he will eliminate the Section 301 tariffs on Chinese goods In #nabjnahj2020 interview, Joe Biden
CPA’s Take: China sees COVID recovery as an economic growth and jobs opportunity. America’s elected officials only think in terms of supply chain resiliency. Why
CPA’s take: The re-layoff phenomenon needs to be considered as Congress deliberates on COVID relief. And you thought the second wave of the coronavirus was
CPA’s take: Millions of people are at risk of being laid off once again after the PPP ends. The US needs to focus on COVID
by Greg Owens | Co-Founder & CEO Sherrill Manufacturing/Liberty Tabletop | Co-Chair CPA Buy American Committee In the face of strong consumer sentiment to buy
By Kenneth Rapoza The Senate Subcommittee on Security held a hearing on China this week. This is what we learned. Ladies and gentlemen, we have
By CPA Staff The Senate takes a stab at reforming the World Trade Organization. But is it even fixable anymore? Yesterday’s Senate Finance Committee hearing
Presses USTR Lighthizer to pursue broad reset of tariffs at WTO Washington. The Coalition for a Prosperous America (CPA) today sent a letter to U.S.
CPA’s take: It’s great to see the Trump administration invoking the DPA to lend Kodak some serious money, great to see a historic US company getting